Enter Note Done
Go to previous page in this tab
Session
  • Presentation | General Poster Session - Monday General Poster Session
  • General Poster Session
  • Share Icon
    Bookmark Icon
  • 2644-P - A Phase 3 Clinical Protocol Evaluating the Safety and Efficacy of NA-931 Alone and in Combination with Oral Semaglutide for the Treatment of Obesity [Board No. 2644]
    • Schedule
    Notes
  • Poster Hall (Halls D-E)
    2644-P
    Set Timezone

L.Tran: None.
Type
Main Session